Gemigliptin, a novel dipeptidyl peptidase-IV inhibitor, exerts a synergistic cytotoxicity with the histone deacetylase inhibitor PXD101 in thyroid carcinoma cells
Titel:
Gemigliptin, a novel dipeptidyl peptidase-IV inhibitor, exerts a synergistic cytotoxicity with the histone deacetylase inhibitor PXD101 in thyroid carcinoma cells
Auteur:
Kim, S. H. Kang, J. G. Kim, C. S. Ihm, S.-H. Choi, M. G. Yoo, H. J. Lee, S. J.